What topics does this cannabis study cover?

This study covers research on: Inflammation.

Where was this research published?

Published in Neurobiology of aging on May 27, 2026.

Inflammation

Cannabis smoke affects aging brains differently than younger ones

Effects of sub-chronic cannabis smoke exposure on inflammatory markers in serum and brain in younger and older mice.

Neurobiology of aging • May 27, 2026 • Moderately Relevant

🤖

AI Summary

This study examined how cannabis smoke exposure affects inflammation in younger (4-month-old) and older (22-month-old) mice, addressing a key gap in cannabinoid research. Researchers exposed mice to either cannabis smoke (5.5-6.2% THC) or placebo smoke daily for 30 days, then measured inflammatory markers in the blood and brain tissue. Aging itself significantly increased inflammatory markers across all tissue types studied, confirming that chronic inflammation is a hallmark of aging.

The findings revealed complex, age-dependent effects of cannabis smoke on brain inflammation. In the hippocampus (critical for memory and learning), cannabis smoke increased inflammation in younger mice but decreased it in older mice—suggesting cannabis may affect aging brains differently than younger ones. However, in the prefrontal cortex (responsible for executive function), cannabis smoke increased inflammation in both age groups. These divergent effects across different brain regions highlight that cannabinoids don't work uniformly throughout the brain.

These results have important implications for aging populations considering cannabis use. While cannabinoids are often promoted for their anti-inflammatory benefits, the effects appear highly dependent on age and brain region. Older adults experiencing age-related cognitive decline might see different outcomes than younger users, and the specific effects on memory-related brain structures versus decision-making areas differ significantly. More research is needed to understand whether these findings in mice translate to humans and to clarify which cannabinoid components drive these age-specific responses.

📄 Original Abstract

Aging is associated with chronic low-grade inflammation, which is thought to contribute to both cognitive decline and various neurodegenerative diseases. Cannabinoids are reported to reduce levels of inflammatory markers; however, these effects have not been thoroughly assessed in older subjects. To address this gap, we evaluated the effects of sub-chronic cannabis smoke exposure on serum and brain inflammatory markers in younger and older mice. Younger (4 month old) and older (22 month old) C57Bl/6J mice were exposed to smoke from burning either cannabis (5.5-6.2% THC) or placebo (0% THC) cigarettes daily for 30 consecutive days. Following exposure sessions, both blood and brain tissue from the prefrontal cortex (PFC) and hippocampus (HPC) were collected and analyzed for multiple markers of inflammation. Overall, the patterns of inflammatory markers varied across serum, PFC, and HPC. Both comparisons of individual cytokines and global cytokine profiles revealed that aging caused increases in cytokine levels in all three sample types. Global cytokine analysis showed increases in PFC inflammatory markers in younger and older mice exposed to cannabis smoke. In contrast, HPC samples had significant Age x Drug interactions, such that cannabis smoke exposure tended to increase cytokine levels in younger mice but decrease them in older mice. These findings point to general age-related increases in serum and brain inflammatory markers in this mouse strain; however, age-dependent cannabis effects were largely restricted to the HPC.

Paper Type

📄 Research

Publication

Journal: Neurobiology of aging
Published: May 27, 2026
PMID: 42214841
DOI: 10.1016/j.neurobiolaging.2026.05.008

Authors (6)

Emely A Gazarov Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA.
Bailey McCracken Department of Psychiatry, University of Florida, Gainesville, FL 32610, USA.
Zachary A Krumm Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA.
Sabrina Zequeira Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA.
Barry Setlow Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Department of Psychiatry, University of Florida, Gainesville, FL 32610, USA; Center for Addiction Research and Education, University of Florida, Gainesville, FL 32610, USA; Center for Cognitive Aging and Memory, University of Florida, Gainesville, FL 32610, USA. Electronic address: setlow@ufl.edu.
+1 more authors